期刊
CHEMICAL SCIENCE
卷 7, 期 11, 页码 6839-6845出版社
ROYAL SOC CHEMISTRY
DOI: 10.1039/c6sc02335e
关键词
-
资金
- Wellcome Trust Strategic [090340/Z/09/Z]
- Pathfinder Awards [107714/Z/15/Z]
- Engineering and Physical Sciences Research Council
- European Research Council [279337/DOS]
- UK Medical Research Council [G1001522]
- Herchel Smith Funds
- Engineering and Physical Sciences Research Council [EP/K039520/1, EP/J016012/1] Funding Source: researchfish
- Medical Research Council [G1001522, MC_UU_12022/8] Funding Source: researchfish
- EPSRC [EP/K039520/1, EP/J016012/1] Funding Source: UKRI
- MRC [MC_UU_12022/8, G1001522] Funding Source: UKRI
The development of selective inhibitors of protein kinases is challenging because of the significant conservation of the ATP binding site. Here, we describe a new mechanism by which the protein kinase CK2 alpha can be selectively inhibited using features outside the ATP site. We have identified a new binding site for small molecules on CK2 alpha adjacent to the ATP site and behind the alpha D loop, termed the aD pocket. An elaborated fragment anchored in this site has been linked with a low affinity fragment binding in the ATP site, creating a novel and selective inhibitor (CAM4066) that binds CK2 alpha with a K-d of 320 nM and shows significantly improved selectivity compared to other CK2 alpha inhibitors. CAM4066 shows target engagement in several cell lines and similar potency to clinical trial candidate CX4945. Our data demonstrate that targeting a poorly conserved, cryptic pocket allows inhibition of CK2 alpha via a novel mechanism, enabling the development of a new generation of selective CK2 alpha inhibitors.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据